Monday, October 20, 2008

Novartis Shows Generics Can Be Tricky Business for Big Pharma

After double-digit growth in 2007 and the first half of 2008, Novartis's generics business showed signs of a slowdown.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)